BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 36091456)

  • 1. Radiolabeling of functional oligonucleotides for molecular imaging.
    Liu D; Xia Q; Ding D; Tan W
    Front Bioeng Biotechnol; 2022; 10():986412. PubMed ID: 36091456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiolabeling of Nucleic Acid Aptamers for Highly Sensitive Disease-Specific Molecular Imaging.
    Hassanzadeh L; Chen S; Veedu RN
    Pharmaceuticals (Basel); 2018 Oct; 11(4):. PubMed ID: 30326601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications.
    Ni D; Jiang D; Ehlerding EB; Huang P; Cai W
    Acc Chem Res; 2018 Mar; 51(3):778-788. PubMed ID: 29489335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo imaging of oligonucleotides with nuclear tomography.
    Duatti A
    Curr Drug Targets; 2004 Nov; 5(8):753-60. PubMed ID: 15578955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiolabeling nanomaterials for multimodality imaging: New insights into nuclear medicine and cancer diagnosis.
    Ge J; Zhang Q; Zeng J; Gu Z; Gao M
    Biomaterials; 2020 Jan; 228():119553. PubMed ID: 31689672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiolabeling of Theranostic Nanosystems.
    Das S; Imlimthan S; Airaksinen AJ; Sarparanta M
    Adv Exp Med Biol; 2021; 1295():49-76. PubMed ID: 33543455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized & Precision Medicine in Cancer: A Theranostic Approach.
    Choudhury P; Gupta M
    Curr Radiopharm; 2017 Nov; 10(3):166-170. PubMed ID: 28758574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET/SPECT molecular imaging in clinical neuroscience: recent advances in the investigation of CNS diseases.
    Lu FM; Yuan Z
    Quant Imaging Med Surg; 2015 Jun; 5(3):433-47. PubMed ID: 26029646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in Targeting Nuclear Molecular Imaging Driven by Tetrazine Bioorthogonal Chemistry.
    Dong P; Wang X; Zheng J; Zhang X; Li Y; Wu H; Li L
    Curr Med Chem; 2020; 27(23):3924-3943. PubMed ID: 31267851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.
    Evangelista L; Briganti A; Fanti S; Joniau S; Reske S; Schiavina R; Stief C; Thalmann GN; Picchio M
    Eur Urol; 2016 Jul; 70(1):161-175. PubMed ID: 26850970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [18F]fluoropyridines: From conventional radiotracers to the labeling of macromolecules such as proteins and oligonucleotides.
    Dollé F
    Ernst Schering Res Found Workshop; 2007; (62):113-57. PubMed ID: 17172154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digital Quantification of Chemical Oligonucleotide Synthesis Errors.
    Filges S; Mouhanna P; Ståhlberg A
    Clin Chem; 2021 Oct; 67(10):1384-1394. PubMed ID: 34459892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single photon emission computed tomography for the diagnosis of coronary artery disease: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(8):1-64. PubMed ID: 23074411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theranostics for Advanced Prostate Cancer: Current Indications and Future Developments.
    Farolfi A; Fendler W; Iravani A; Haberkorn U; Hicks R; Herrmann K; Walz J; Fanti S
    Eur Urol Oncol; 2019 Mar; 2(2):152-162. PubMed ID: 31017091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiolabeled oligonucleotides for antisense imaging.
    Iyer AK; He J
    Curr Org Synth; 2011 Aug; 8(4):604-614. PubMed ID: 21822406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
    Zanzonico P; Dauer L; St Germain J
    Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivity-Based Organic Theranostic Bioprobes.
    Kenry ; Chong KC; Liu B
    Acc Chem Res; 2019 Nov; 52(11):3051-3063. PubMed ID: 31588730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 68Ga-labeled oligonucleotides for in vivo imaging with PET.
    Roivainen A; Tolvanen T; Salomäki S; Lendvai G; Velikyan I; Numminen P; Välilä M; Sipilä H; Bergström M; Härkönen P; Lönnberg H; Långström B
    J Nucl Med; 2004 Feb; 45(2):347-55. PubMed ID: 14960659
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.